Company
Ferring Pharmaceuticals
Ferring Pharmaceuticals has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Nadofaragene Firadenovec | Phase 3 | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ |
Latest
No recent events.
Follow Ferring Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.